Profile
Duret Jean Michael Christophe worked as the Chief Executive Officer at Novo Nordisk Scandinavia AB from 2008 to 2012.
He also worked as the President at HemoCue AB.
Former positions of Duret Jean Michael Christophe
| Companies | Position | End |
|---|---|---|
HemoCue AB
 HemoCue AB Medical SpecialtiesHealth Technology HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing. Its solutions include hematology, diabetes, data management and connectivity solutions, and accessories and consumables. The company was founded in 1982 and is heaquartered in Angelholm, Sweden. | President | 01/11/2022 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Chief Executive Officer | 01/01/2012 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
HemoCue AB
HemoCue AB Medical SpecialtiesHealth Technology HemoCue AB develops, produces, and markets medical diagnostic products for point of care testing. Its solutions include hematology, diabetes, data management and connectivity solutions, and accessories and consumables. The company was founded in 1982 and is heaquartered in Angelholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Duret Jean Michael Christophe
